Apellis Pharmaceuticals Inc Ano de IPO
Qual é o Ano de IPO de Apellis Pharmaceuticals Inc?
O Ano de IPO de Apellis Pharmaceuticals Inc é 1970
Qual é a definição de Ano de IPO?
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Ano de IPO de empresas na Setor Health Care em NASDAQ em comparação com Apellis Pharmaceuticals Inc
O que Apellis Pharmaceuticals Inc faz?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Empresas com ano de ipo semelhantes a Apellis Pharmaceuticals Inc
- Vanguard FTSE Developed Europe ex UK ETF tem Ano de IPO de 1969
- Apellis Pharmaceuticals Inc tem Ano de IPO de 1970
- PepsiCo Inc tem Ano de IPO de 1972
- Applied Materials tem Ano de IPO de 1972
- L&T Finance tem Ano de IPO de 1972
- Coca-Cola Consolidated Inc tem Ano de IPO de 1972
- GT Biopharma tem Ano de IPO de 1972
- Jacobs Solutions Inc tem Ano de IPO de 1972